Candel Therapeutics at canaccord growth conference: prostate cancer push — See source for full details.
$CADL
Price history, market instrument context, member research, and related headlines in one place.
CADL key statistics
NasdaqGMUSD
52-week range
$4.3549%$14.00
Latest session $9.03–$9.43Candel Therapeutics, Inc. (CADL) is a stock instrument quoted on NasdaqGM in USD. The most recently published price is $9.07, down $0.20 (2.16%) from the previous close of $9.27. It has traded between $9.03 and $9.43 in the latest session. Over the past year it has ranged from $4.35 to $14.00, leaving it around the middle of its 52-week range (49%). Reported volume for the session was 988.8K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $CADL research…